{"name":"Lepu Medical","slug":"lepu-medical","ticker":"300003.SZ","exchange":"SZSE","domain":"lepumedical.com","description":"Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro diagnostics, surgical instruments, peripheral blood vessels, blood purification, ultrasound imaging, and orthopedic products; pharmaceutical products for cardiovascular, digestive, central nervous, and respiratory systems, as well as antimicrobial, nutrition, traditional Chinese medicine, lowering blood sugar, and health food; and medical services and health management, such as medical services, AI, home appliances, and medical aesthetics and daily chemical products. The company is also involved in investment activities; trading; technological development; and pension services. It exports its pr","hq":"Beijing, China","founded":1999,"employees":"8689","ceo":"Pu Zhongjie","sector":"Cardiovascular Devices & Pharma","stockPrice":13.72,"stockChange":-0.64,"stockChangePercent":-4.46,"marketCap":"$3.7B","metrics":{"revenue":945978960.0295987,"revenueGrowth":-3.7,"grossMargin":61.7,"rdSpend":0,"netIncome":122368268.04966591,"cash":588077880.9508607,"dividendYield":2.07,"peRatio":30.5,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Lepu Medical's Cardiovascular Stent patent cliff ($100MB at risk)","drug":"Lepu Medical's Cardiovascular Stent","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Single anti-platelet therapy","genericName":"Single anti-platelet therapy","slug":"single-anti-platelet-therapy","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Single anti-platelet therapy","genericName":"Single anti-platelet therapy","slug":"single-anti-platelet-therapy","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2022-06-30","type":"earnings","headline":"Lepu Medical Reports 2021 Annual Results","summary":"Lepu Medical reported a revenue increase of 15% in 2021, driven by strong sales of its cardiovascular stents and pacemakers.","drugName":"","sentiment":"positive"},{"date":"2020-03-12","type":"deal","headline":"Lepu Medical Partners with US-Based Medical Device Company","summary":"Lepu Medical announced a partnership with a US-based medical device company to co-develop and market new cardiovascular products.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQVkU1TXFiTE54T1U2UGJlSnNfRkVHYUdaS28wam1EVS1XUEd6NllIWnBkXzlQWmc1aENIZVhfNVYwakMyOFRzQ1Jnbm9YeDdxUEREY19PUUJsZWpFLXF5SzJtMHVjaDhOYUZWS3d1YWxRTUpmZzhaUkVUVGkyUXMyWmt0c3FUMUtPLW5lMUJlbGh0bVQ4aDlWdzlseW5oRUwyTTlr?oc=5","date":"2026-01-06","type":"pipeline","source":"Moomoo","summary":"Brain-computer interfaces ignite the market at the start of the year; is a new trend emerging? Which public funds have already taken positions? - Moomoo","headline":"Brain-computer interfaces ignite the market at the start of the year; is a new trend emerging? Which public funds have a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOUEZsSWx4QWdYYVltWGJhS1JDWU5razUtcHlXXzQzQXBEanFJUWZjWFBVcnJDazlrWEJWcjZLYlQ4MkFESzNxZ1hocU1NZE0xVXRIMWZmMkhjYm1KZEw3eDhnSzJpdXhzeWxicUIwNHoza1BEWTN2QnRmZEhKYkRqMzJ2cTJQWFU0MURaczkwWTlPMU5pQ3BMNlMxS1ctOEoz?oc=5","date":"2022-12-12","type":"pipeline","source":"Reuters","summary":"China COVID infection fears fuel medical stock bets - Reuters","headline":"China COVID infection fears fuel medical stock bets","sentiment":"neutral"}],"patents":[{"drugName":"Lepu Medical's Cardiovascular Stent","drugSlug":"none","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":100000000000}],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Medtronic","Boston Scientific","Abbott Laboratories"],"therapeuticFocus":["Cardiovascular Devices","Pharmaceuticals"],"financials":{"source":"yahoo_finance","revenue":955436472.9043143,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":955436472.9043143},{"period":"2024-12-31","value":899510603.6109118},{"period":"2023-12-31","value":1176091686.165077},{"period":"2022-12-31","value":1563638352.5527844}],"grossProfit":611556363.4960207,"grossProfitHistory":[{"period":"2025-12-31","value":611556363.4960207},{"period":"2024-12-31","value":547614947.6373125},{"period":"2023-12-31","value":755569362.0484914},{"period":"2022-12-31","value":976574638.5527029}],"rdSpend":116782099.11550246,"rdSpendHistory":[{"period":"2025-12-31","value":116782099.11550246},{"period":"2024-12-31","value":113418707.45039903},{"period":"2023-12-31","value":129610244.32418998},{"period":"2022-12-31","value":141053501.55075017}],"sgaSpend":116085281.60283804,"operatingIncome":226761846.9925255,"operatingIncomeHistory":[{"period":"2025-12-31","value":226761846.9925255},{"period":"2024-12-31","value":105666236.6061607},{"period":"2023-12-31","value":271863500.92905957},{"period":"2022-12-31","value":421340842.2422594}],"netIncome":141782196.03947997,"netIncomeHistory":[{"period":"2025-12-31","value":141782196.03947997},{"period":"2024-12-31","value":36394117.59014644},{"period":"2023-12-31","value":185435792.78040227},{"period":"2022-12-31","value":324796904.9224625}],"eps":0.5219,"epsHistory":[{"period":"2025-12-31","value":0.5219},{"period":"2024-12-31","value":0.1336},{"period":"2023-12-31","value":0.6757},{"period":"2022-12-31","value":1.2129}],"cash":652832697.2211846,"cashHistory":[{"period":"2025-12-31","value":652832697.2211846},{"period":"2024-12-31","value":547967913.2522721},{"period":"2023-12-31","value":622062314.1592444},{"period":"2022-12-31","value":805777224.4742284}],"totalAssets":3852362665.1834435,"totalLiabilities":1234904180.000907,"totalDebt":941473212.7633756,"equity":2375068507.438763,"operatingCashflow":223566454.28606522,"operatingCashflowHistory":[{"period":"2025-12-31","value":223566454.28606522},{"period":"2024-12-31","value":108273116.69082026},{"period":"2023-12-31","value":145960982.36987913},{"period":"2022-12-31","value":411299677.224081}],"capex":-94774757.9441477,"capexHistory":[{"period":"2025-12-31","value":-94774757.9441477},{"period":"2024-12-31","value":-97098184.02052452},{"period":"2023-12-31","value":-124488844.24534065},{"period":"2022-12-31","value":-133412267.16521497}],"freeCashflow":128791696.3419175,"dividendsPaid":-100447630.39602183,"buybacks":null,"employees":8689,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":55381976.53636705,"ebit":59860748.179722734,"ebitda":59860748.179722734,"period":"2026-03-31","revenue":246431333.89858028,"epsBasic":0.1339,"netIncome":36375944.952179044,"rdExpense":35451746.02236835,"epsDiluted":0.1339,"grossProfit":152872086.88615018,"operatingIncome":62160577.403050154},{"sga":-74604134.16878454,"ebit":14688374.274013067,"ebitda":14688374.274013067,"period":"2025-12-31","revenue":227560765.92933905,"epsBasic":null,"netIncome":-2954516.600310045,"rdExpense":29206196.359390058,"epsDiluted":null,"grossProfit":144208514.0516057,"operatingIncome":30456276.06845377},{"sga":-14606677.956140006,"ebit":60144328.58261144,"ebitda":60144328.58261144,"period":"2025-06-30","revenue":240697024.49664596,"epsBasic":null,"netIncome":46040009.42329671,"rdExpense":28237686.485846885,"epsDiluted":null,"grossProfit":155273072.77521417,"operatingIncome":64982728.18225594},{"sga":64471427.645015694,"ebit":75111547.85966203,"ebitda":75111547.85966203,"period":"2025-03-31","revenue":255888835.20824835,"epsBasic":0.2053,"netIncome":55789872.64133429,"rdExpense":29966549.021209482,"epsDiluted":0.2053,"grossProfit":163833096.7492463,"operatingIncome":73683897.74966353},{"sga":-72434532.33666484,"ebit":-92016606.61383459,"ebitda":-92016606.61383459,"period":"2024-12-31","revenue":194219324.8548644,"epsBasic":null,"netIncome":-81902727.61598049,"rdExpense":31319031.113891963,"epsDiluted":null,"grossProfit":104696870.98395109,"operatingIncome":-41101033.59890953}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":13.72,"previousClose":14.36,"fiftyTwoWeekHigh":21.6,"fiftyTwoWeekLow":11.12,"fiftyTwoWeekRange":"11.12 - 21.6","fiftyDayAverage":16.04,"twoHundredDayAverage":17.18,"beta":0.23,"enterpriseValue":4198556250.133381,"forwardPE":19.1,"priceToBook":1.54,"priceToSales":3.94,"enterpriseToRevenue":4.44,"enterpriseToEbitda":0,"pegRatio":0,"ebitda":0,"ebitdaMargin":0,"freeCashflow":10411128.40848288,"operatingCashflow":202325656.12626687,"totalDebt":832721620.7715839,"debtToEquity":31.4,"currentRatio":2.38,"returnOnAssets":2.9,"returnOnEquity":4.9,"analystRating":"","recommendationKey":"none","numberOfAnalysts":5,"targetMeanPrice":20.11,"targetHighPrice":24,"targetLowPrice":16.4,"dividendRate":0.3,"payoutRatio":0.66,"fiveYearAvgDividendYield":1.96,"exDividendDate":1758585600,"insiderHeldPercent":38.6,"institutionHeldPercent":12.3,"sharesOutstanding":1843424716,"floatShares":1131696867,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":0.45,"epsForward":0.72,"revenuePerShare":3.48,"bookValue":8.92,"officers":[{"age":62,"name":"Dr. Zhongjie  Pu","title":"Chairman & CTO"},{"age":36,"name":"Ms. Fei  Pu","title":"CEO & Non Independent Director"},{"age":46,"name":"Ms. Weina  Jiang","title":"Secretary of the Board"},{"age":53,"name":"Mr. Zhan Jiang  Wei","title":"Senior Deputy General Manager"},{"age":45,"name":"Mr. Bing Feng  Zhang","title":"Deputy General Manager"},{"age":51,"name":"Ms. Xiaoying  Feng","title":"Deputy General Manager"}],"industry":"Medical Devices","irWebsite":"http://www.lepumedical.com/a/touzizhe/","website":"https://www.lepumedical.com","phone":"86 10 5830 5102"}}